The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...

The Gila monster is a large, magnificent, and venomous desert-dwelling reptile found throughout the southwestern US and Mexico. A toxic bite from the Gila can cause searing pain, loss of consciousness ...

Ozempic is given as a weekly dose. Each pen has several doses ... any time of day 4 mg/3 mL, used for maintenance dosages 1 mg, given after 4 weeks of the 0.5-mg dose if blood sugar levels ...

Novo Nordisk notified the Food and Drug Administration about several hundred units of fake semaglutide 1.0 mg in the US drug ...

The active ingredient in Ozempic is semaglutide, and the active ingredient in Trulicity is dulaglutide. Both of these drugs belong to a class of medications called glucagon-like peptide-1 receptor ...

In studies of Ozempic for type 2 diabetes, 20.3% of participants taking a 1-milligram (mg) dose of Ozempic reported feeling nauseous, compared to 6.1% of those given a placebo. Higher doses are ...

Novo Nordisk A/S (NYSE:NVO) said it had become aware of several hundred units of Ozempic (semaglutide) injection 1 mg ...

Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial investigating the effects of once-weekly ...

the dose may be increased to 1 mg once weekly. In some cases, healthcare providers may prescribe up to 2 mg once weekly. Ozempic should be injected subcutaneously in the abdomen, thigh ...